250 related articles for article (PubMed ID: 37900001)
1. Therapeutic Potential Targeting Podocyte Mitochondrial Dysfunction in Focal Segmental Glomerulosclerosis.
Li Y; Fan J; Zhu W; Niu Y; Wu M; Zhang A
Kidney Dis (Basel); 2023 Aug; 9(4):254-264. PubMed ID: 37900001
[TBL] [Abstract][Full Text] [Related]
2. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.
Daehn I; Casalena G; Zhang T; Shi S; Fenninger F; Barasch N; Yu L; D'Agati V; Schlondorff D; Kriz W; Haraldsson B; Bottinger EP
J Clin Invest; 2014 Apr; 124(4):1608-21. PubMed ID: 24590287
[TBL] [Abstract][Full Text] [Related]
3. The role of podocyte injury in the pathogenesis of focal segmental glomerulosclerosis.
Schwartz MM
Ren Fail; 2000 Nov; 22(6):663-84. PubMed ID: 11104157
[TBL] [Abstract][Full Text] [Related]
4. Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis.
Kim JS; Han BG; Choi SO; Cha SK
Biomed Res Int; 2016; 2016():1630365. PubMed ID: 27088082
[TBL] [Abstract][Full Text] [Related]
5. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
[TBL] [Abstract][Full Text] [Related]
6. Update on Recurrent Focal Segmental Glomerulosclerosis in Kidney Transplantation.
Shoji J; Mii A; Terasaki M; Shimizu A
Nephron; 2020; 144 Suppl 1():65-70. PubMed ID: 33260184
[TBL] [Abstract][Full Text] [Related]
7. Pathobiology of focal segmental glomerulosclerosis: new developments.
D'Agati VD
Curr Opin Nephrol Hypertens; 2012 May; 21(3):243-50. PubMed ID: 22357339
[TBL] [Abstract][Full Text] [Related]
8. Protecting Podocytes: A Key Target for Therapy of Focal Segmental Glomerulosclerosis.
Campbell KN; Tumlin JA
Am J Nephrol; 2018; 47 Suppl 1(Suppl 1):14-29. PubMed ID: 29852493
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor MafB in podocytes protects against the development of focal segmental glomerulosclerosis.
Usui T; Morito N; Shawki HH; Sato Y; Tsukaguchi H; Hamada M; Jeon H; Yadav MK; Kuno A; Tsunakawa Y; Okada R; Ojima T; Kanai M; Asano K; Imamura Y; Koshida R; Yoh K; Usui J; Yokoi H; Kasahara M; Yoshimura A; Muratani M; Kudo T; Oishi H; Yamagata K; Takahashi S
Kidney Int; 2020 Aug; 98(2):391-403. PubMed ID: 32622525
[TBL] [Abstract][Full Text] [Related]
10. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
[TBL] [Abstract][Full Text] [Related]
11. Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis.
Taneda S; Honda K; Ohno M; Uchida K; Nitta K; Oda H
Virchows Arch; 2015 Oct; 467(4):449-58. PubMed ID: 26266776
[TBL] [Abstract][Full Text] [Related]
12. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
[TBL] [Abstract][Full Text] [Related]
13. Focal segmental glomerulosclerosis with a mutation in the
Naganuma T; Imasawa T; Nukui I; Wakasugi M; Kitamura H; Yatsuka Y; Kishita Y; Okazaki Y; Murayama K; Jinguji Y
Mol Genet Metab Rep; 2023 Jun; 35():100963. PubMed ID: 36941957
[TBL] [Abstract][Full Text] [Related]
14. [The role of podocyte damage in the pathogenesis of glomerulosclerosis and possible repair mechanisms].
Ronconi E; Mazzinghi B; Sagrinati C; Angelotti ML; Ballerini L; Parente E; Romagnani P; Lazzeri E; Lasagni L
G Ital Nefrol; 2009; 26(6):660-9. PubMed ID: 19918748
[TBL] [Abstract][Full Text] [Related]
15. Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis.
Otalora L; Chavez E; Watford D; Tueros L; Correa M; Nair V; Ruiz P; Wahl P; Eddy S; Martini S; Kretzler M; Burke GW; Fornoni A; Merscher S
PLoS One; 2019; 14(10):e0222948. PubMed ID: 31581251
[TBL] [Abstract][Full Text] [Related]
16. Focal segmental glomerulosclerosis; why does it occur segmentally?
Nagata M; Kobayashi N; Hara S
Pflugers Arch; 2017 Aug; 469(7-8):983-988. PubMed ID: 28664408
[TBL] [Abstract][Full Text] [Related]
17. New Mutation of Coenzyme Q
Song CC; Hong Q; Geng XD; Wang X; Wang SQ; Cui SY; Guo MD; Li O; Cai GY; Chen XM; Wu D
Chin Med J (Engl); 2018 Nov; 131(22):2666-2675. PubMed ID: 30425193
[TBL] [Abstract][Full Text] [Related]
18. A Novel CLCN5 Mutation Associated With Focal Segmental Glomerulosclerosis and Podocyte Injury.
Solanki AK; Arif E; Morinelli T; Wilson RC; Hardiman G; Deng P; Arthur JM; Velez JC; Nihalani D; Janech MG; Budisavljevic MN
Kidney Int Rep; 2018 Nov; 3(6):1443-1453. PubMed ID: 30426109
[TBL] [Abstract][Full Text] [Related]
19. Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress.
Raij L; Tian R; Wong JS; He JC; Campbell KN
Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1308-F1317. PubMed ID: 27335373
[TBL] [Abstract][Full Text] [Related]
20. Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS.
Zhang J; Pippin JW; Krofft RD; Naito S; Liu ZH; Shankland SJ
Am J Physiol Renal Physiol; 2013 Jun; 304(11):F1375-89. PubMed ID: 23486009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]